KARDIOVASKULÁRNÍ RIZIKO U PACIENTŮ HOSPITALIZOVANÝCH NA INTERNÍM ODDĚLENÍ: PRŮŘEZOVÁ STUDIE

Aneta Hujová; Miroslava Zemanová

doi:10.46585/hc.2024.1.2513

Authors

Aneta Hujová Jan Evangelista Purkyně University in Ústí nad Labem, Faculty of Health Studies, Department of Nursing https://orcid.org/0000-0003-3773-2902
Miroslava Zemanová Jan Evangelista Purkyně University in Ústí nad Labem, Faculty of Health Studies, Department of Nursing https://orcid.org/0000-0002-4494-9002

DOI:

https://doi.org/10.46585/hc.2024.1.2513

Keywords:

fatální kardiovaskulární příhoda, kardiovaskulární onemocnění, kardiovaskulární riziko, nomogram SCORE

Abstract

Introduction: The SCORE (Systematic Coronary Risk Evaluation system) is one of the most widely used scoring systems for the Czech population. This system identifies possible fatal cardiovascular events in the next 10 years or at the age of 60 years, therefore it is possible to detect asymptomatic young individuals at low cardiovascular risk but with an unhealthy lifestyle, which may shift to high cardiovascular risk.

Aim: The aim of the study was to determine the percentage of cardiovascular risk in patients admitted to an internal medicine ward (n = 64, 44% female; 56% male) from April 1 - November 1, 2023.

Methods: Inclusion criteria for inclusion in the study: hospitalization from April 1 - November 1, 2023; signed written informed consent; untreated cardiovascular disease; undiagnosed type I and II diabetes mellitus or undiagnosed renal failure. Data were obtained by personal interview (age, smoking abstinence), after which systolic blood pressure was measured. Subsequently, venous blood was drawn and total cholesterol (mmol/l) was determined. All these data were then compared with the SCORE nomogram for high-risk countries.

Results: The results showed that more than 57 % of the respondents were at no risk of fatal cardiovascular events, 18,8 % were at intermediate risk and 23,5 % were at high risk.

Conclusion: The average risk of developing a cardiovascular event in the next 10 years or at the age of 60 years was in the low range (0-2 %) for most patients, but further research and a larger sample of patients are needed to determine the exact risk factors

Downloads

Download data is not yet available.

References

Csenteriová, O., Jancsó, Z., Szöllösi, G. J., Andréka, P. & Vajer, P. (2022). Differences of cardiovascular risk assessment in clinical practise useing SCORE and SCORE 2. Open heart, 9(2), e002087. 10.1136/openhrt-2022-002087

ESC/ESH Guidelines (2018). Clinical Practice Guidelines for the Management of Arterial Hypertension. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Arterial-Hypertension-Management-of

Filipovský, J., Widimský jr., J. & Špinar, J. (2014). Summary of 2013 ESH/ESC Guidelines for the management of arterial hypertension. Prepared by the Czech Society of Hypertension/Czech Society of Cardiology. Cor et Vasa, 56, e494-e518. http://www.sciencedirect.com/science/article/pii/

S0010865014000769

Musil, V., Špinar, J., Pozdíšek, Z., Ludka, O., Lokaj, P., Felšöci, M., Plachý, M., Balcárková, Janoušová, E., Jarkovský, J., Pavlík, T., Schwarz, D. & Dušek, L. (2009). Kdo káže vodu a pije víno – kardiovaksulární riziko v medicínské populaci v projektu. Kardiologická revue – Interní medicína, 11(4), 204-208. https://www.prolekare.cz/casopisy/kardiologicka-revue/2009-4/kdo-kaze-vodu-a-pije-vino-kardiovaskularni-riziko-v-medicinske-populaci-v-projektu-31358

Powellová, K. L., Stephens, S. R. & Stephns, A. S. (2021). Cardiovascular risk factor mediation of the effect of education and Genetic Risk Score on cardiovascular disease: a prospective observational cohort study of the Framingham Heart Study. BMJ open, 11(1), e045210. https://doi.org/10.1136/bmjopen-2020-045210

Rojíček, M. & Štygletová, T. (2021). Příčiny smrti v roce 2020. Český statistická úřad. https://www.czso.cz/documents/10180/163378569/csu_tk_priciny_smrti_prezentace.pdf/b87f04e6-ca7a-4c3e-9a1b-8eef3fe1c32d?version=1.0

Samanivan Bavarsad, P., Kheiri S., & Ahmadi, A. (2020). Estimation of the 10-Year Risk of Cardiovascular Diseases: Using the SCORE, WHO/ISH, and Framingham Models in the Shahrekord Cohort Study in Southwestern Iran. The journal of Tehran Heart Center, 15(3), 105–112. https://doi.org/10.18502/jthc.v15i3.4219

Score2 working group and ESC Cardiovascular risk collaboration (2021). SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. European Heart Journal. 2021, 41(25), 249-2454. https://doi.org/10.1093/eurheartj/ehab309

Tůmová, E. & Vráblík, M. (2017). Stratifikace kardiovaskulárního rizika a nové cílové hodnoty sérových lipidů. Kardiologická revue – Interní medicína, 19(3), 152-156. https://www.kardiologickarevue.cz/casopisy/kardiologicka-revue/2017-3/stratifikace-kardiovaskularniho-rizika-a-nove-cilove-hodnoty-serovych-lipidu-61751

Zikmund Galková, L., Špinar, J. & Ludka, O. (2015). Skórovací systémy preventivní kardiologie. Kardiologická revue – Interní medicína. 17(2), 112-116 https://www.kardiologickarevue.cz/casopisy/kardiologicka-revue/2015-2/skorovaci-systemy-preventivni-kardiologie-52098